FDA Clears SurGenTec’s Synthetic Bone Graft

SurGenTec has received a 510(k) clearance from the FDA for its OsteoFlo NanoPutty, a synthetic bone graft that requires no mixing or preparation before use.

The bone graft uses nanotechnology to increase the surface area for bone growth and to stimulate cellular activity and osseointegration. The product is designed to promote the growth of bone at different phases during the healing process.  

The graft is available in two delivery formats, a standard syringe and a minimally invasive cartridge used with the company’s GraftGun system.